Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study.
Joeri W van StraalenSytze de RoockGabriella GiancaneAlessandro ConsolaroMarite RyggEllen B NordalNadina Rubio-PérezMarija JelusicJaime De InocencioJelena VojinovicNico M WulffraatPatricia C J Bruijning-VerhagenNicolino RupertoJoost F Swartnull nullPublished in: Pediatric rheumatology online journal (2022)
Both ETN and ADA improve well-being in non-systemic JIA. Our data might indicate a trend towards a slightly stronger effect for ETN, but larger studies are needed to confirm this given the lack of statistical significance.